Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FEZOLINETANT vs FILGRASTIM-AAFI: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FEZOLINETANT vs FILGRASTIM-AAFI: Safety Overview

Metric FEZOLINETANT FILGRASTIM-AAFI
Total FAERS Reports 1,407 439
Deaths Reported 1 80
Death Rate 0.1% 18.2%
Hospitalizations 32 117
Average Patient Age 59.0 yrs 54.8 yrs
% Female Patients 98.6% 60.0%
FDA Approval Date May 12, 2023 N/A
Manufacturer Astellas Pharma US, Inc. N/A
Route ORAL N/A
Marketing Status Prescription Prescription